{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Side+Effects&page=22", "query": { "condition": "Side Effects", "page": 22 }, "page_size": 10 }, "pagination": { "page": 22, "page_size": 10, "total_count": 1096, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Side+Effects&page=23&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Side+Effects&page=21&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T02:02:16.485Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05451810", "title": "A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diffuse Large B-Cell Lymphoma", "Classic Follicular Lymphoma" ], "interventions": [ { "name": "Epcoritamab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genmab", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 184, "start_date": "2022-08-17", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 70, "location_summary": "Mobile, Alabama • Little Rock, Arkansas • Springdale, Arkansas + 60 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05451810" }, { "nct_id": "NCT05145959", "title": "Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stevens-Johnson Syndrome", "Toxic Epidermal Necrolyses", "Ocular Surface Disease", "Meibomitis", "Meibomian Gland Dysfunction", "Dry Eye" ], "interventions": [ { "name": "Maskin Probe", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts Eye and Ear Infirmary", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2021-12-01", "completion_date": "2024-03-01", "has_results": false, "last_update_posted_date": "2021-12-06", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05145959" }, { "nct_id": "NCT00005796", "title": "Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bone Marrow Suppression", "Brain and Central Nervous System Tumors", "Drug/Agent Toxicity by Tissue/Organ" ], "interventions": [ { "name": "filgrastim", "type": "PROCEDURE" }, { "name": "gene therapy", "type": "BIOLOGICAL" }, { "name": "lomustine", "type": "DRUG" }, { "name": "procarbazine hydrochloride", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "in vitro-treated peripheral blood stem cell transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL", "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 10, "start_date": "2000-02", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2015-03-25", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 2, "location_summary": "Indianapolis, Indiana • Boston, Massachusetts", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005796" }, { "nct_id": "NCT01924182", "title": "Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain" ], "interventions": [ { "name": "SynchroMed Infusion System and Intrathecal Morphine Sulfate", "type": "DEVICE" }, { "name": "Conventional Medicine", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "MedtronicNeuro", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2013-10", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2018-03-29", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 6, "location_summary": "Homewood, Alabama • Napa, California • Walnut Creek, California + 3 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Napa", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01924182" }, { "nct_id": "NCT07160179", "title": "Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Geographic Atrophy", "Age-Related Macular Degeneration" ], "interventions": [ { "name": "ABBV-6628", "type": "DRUG" }, { "name": "SYFOVRE", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 66, "start_date": "2025-08-13", "completion_date": "2029-10", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 5, "location_summary": "Carmel, Indiana • Reno, Nevada • Abilene, Texas + 2 more", "locations": [ { "city": "Carmel", "state": "Indiana" }, { "city": "Reno", "state": "Nevada" }, { "city": "Abilene", "state": "Texas" }, { "city": "Dallas", "state": "Texas" }, { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07160179" }, { "nct_id": "NCT00024427", "title": "Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Drug/Agent Toxicity by Tissue/Organ", "Pancreatic Cancer" ], "interventions": [ { "name": "fluorouracil", "type": "DRUG" }, { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "triacetyluridine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wellstat Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2001-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-06-28", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Burbank, California • Duarte, California + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Burbank", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00024427" }, { "nct_id": "NCT04993261", "title": "An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Carcinoid Syndrome", "Carcinoid Tumor", "Digestive System Neuroendocrine Tumor G1", "Metastatic Carcinoid Tumor" ], "interventions": [ { "name": "Dual-Energy Computed Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2015-09-23", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04993261" }, { "nct_id": "NCT07249528", "title": "A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Non-hodgkin Lymphoma", "Multiple Myeloma" ], "interventions": [ { "name": "Audio Tasks", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2026-04-17", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 8, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07249528" }, { "nct_id": "NCT00068081", "title": "Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Zoster", "Neuralgia", "Pain", "Peripheral Nervous System Diseases" ], "interventions": [ { "name": "Capsaicin Dermal Patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeurogesX", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2008-03-06", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 19, "location_summary": "Mesa, Arizona • Peoria, Arizona • Phoenix, Arizona + 15 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00068081" }, { "nct_id": "NCT05458843", "title": "Renal Considerations in the Heat Stress Recommendations (Aim2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hot Weather; Adverse Effect", "Kidney Dysfunction", "Kidney Injury", "Hyperthermia", "Dehydration" ], "interventions": [ { "name": "Fluid replacement", "type": "PROCEDURE" }, { "name": "No fluid replacement", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "ALL", "summary": "18 Years to 44 Years" }, "enrollment_count": 18, "start_date": "2022-08-01", "completion_date": "2023-05-22", "has_results": false, "last_update_posted_date": "2023-11-08", "last_synced_at": "2026-10-25T02:02:16.485Z", "location_count": 1, "location_summary": "Bloomington, Indiana", "locations": [ { "city": "Bloomington", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05458843" } ] }